Search results
Results from the WOW.Com Content Network
Apple M2 is a series of ARM-based system on a chip (SoC) designed by Apple Inc., launched 2022 to 2023.It is part of the Apple silicon series, as a central processing unit (CPU) and graphics processing unit (GPU) for its Mac desktops and notebooks, the iPad Pro and iPad Air tablets, and the Vision Pro mixed reality headset.
The new MacBook Air takes on hardware design cues from the 14" and 16" MacBook Pro notebooks released on October 26, 2021, such as a thinner, lighter, flat chassis with 20% less volume than the previous MacBook Air. Other features include MagSafe 3, which also supports fast charging up to 50% in 30 minutes with a 67W or greater power adapter, a ...
On June 6, 2022, at WWDC 2022, Apple announced an updated MacBook Air based on the M2 system on a chip. [20] It incorporates several design elements from the M1 Pro and M1 Max MacBook Pro models, such as a flat, slab-shaped design, full-sized function keys, and a Liquid Retina display with rounded corners and a notch for a 1080p webcam.
As part of the Mac transition to Intel processors, Apple released a 13-inch laptop simply named "MacBook", as a successor to the PowerPC-based iBook series of laptops. . During its existence, it was the most affordable Mac, serving as the entry-level laptop that was less expensive than the rest of the Mac laptop lineup (the MacBook Pro portable workstation, and later the MacBook Air ultra-port
Experience AOL Desktop Gold, a faster and more secure way to navigate the online world. Try it free* for 30 days!
Download System Mechanic to help repair and speed up your slow PC. Try it free* for 30 days now.
[2] [75] Apple released an entry-level version of the 13-inch MacBook Pro on October 27, 2016, which was specifically targeted towards MacBook Air users. [76] A Retina MacBook Air was released in late 2018. The 11.6-inch MacBook Air, introduced in October 2010, is only slightly larger and heavier (when closed) than the iPad 2. The 11.6-inch Air ...
An additional cohort from the ongoing placebo-controlled Phase 1b trial of CT-388 will evaluate obese patients (BMI>30 kg/m2) with type 2 diabetes over a 12-week treatment duration. ... In Other News.